Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 4.06 USD 0.25% Market Closed
Market Cap: 620.4m USD
Have any thoughts about
Mereo Biopharma Group PLC?
Write Note

Mereo Biopharma Group PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mereo Biopharma Group PLC
Revenue Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
Revenue
ÂŁ10m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Revenue
$6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Revenue
$1.7m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Revenue
$36.9m
CAGR 3-Years
46%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Revenue
ÂŁ249.4m
CAGR 3-Years
102%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Revenue
ÂŁ668.8m
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
6%

See Also

What is Mereo Biopharma Group PLC's Revenue?
Revenue
10m GBP

Based on the financial report for Dec 31, 2023, Mereo Biopharma Group PLC's Revenue amounts to 10m GBP.

Back to Top